A Research Codex ~ Correspondence
Contact TB-500 Pharmacy
For corrections, citations, and editorial correspondence about the TB-500 record — not for clinical or purchasing inquiries.
Write to the editor
Contact TB-500 Pharmacy for editorial matters about this digest of the TB-500 and thymosin beta-4 literature: a correction, a study we should add to the register, or a question about how we have read a source. We welcome scrutiny of our citations — the value of a codex is only as good as the sources sealed into it.
This is an editorial mailbox, not a clinical or commercial one. We cannot answer questions about obtaining TB-500, cannot recommend doses, cannot direct you to a pharmacy, clinic, telehealth provider, or vendor, and do not sell or supply any substance. Inquiries of that kind fall outside what this project does and will not receive a substantive reply.
What to include
A useful correction names the page, quotes the sentence, and cites the source you believe is more accurate — a PubMed identifier, a DOI, or an FDA page. For regulatory matters, note that this codex states only present-tense, FDA-citable facts and does not assert any future FDA action as certain; corrections grounded in authoritative primary sources are the ones we can act on.
Use the form below. Because we are a small editorial project and not a service desk, we read correspondence in batches and reply selectively, prioritizing well-sourced corrections to the record.